Sinhang Cheng is currently an MB candidate at Peking University, Beijing, China, where she is expected to receive her MB degree in 2028. Her research focuses on microbiome-targeted interventions, with a particular interest in the role of the gut microbiome in gastrointestinal cancer therapy and the development of microbiota-based therapeutic strategies. She has engaged in literature research on microbiome modulation and its clinical translation, and is committed to pursuing a career in translational medicine.
Sinhang Cheng is currently an MB candidate at Peking University, Beijing, China, where she is expected to receive her MB degree in 2028. Her research focuses on microbiome-targeted interventions, with a particular interest in the role of the gut microbiome in gastrointestinal cancer therapy and the development of microbiota-based therapeutic strategies. She has engaged in literature research on microbiome modulation and its clinical translation, and is committed to pursuing a career in translational medicine.